AtherosclerosisVolume 151, Issue 1, July 2000, Page 53Long-term effects of NK-104 (itavastatin), a new HMG-CoA reductase inhibitor, in patients with heterozygous familial hypercholesterolemiaAuthor links open overlay panelH Mabuchi, Hokuriku FH Study GroupShow moreShareCitehttps://doi.org/10.1016/S0021-9150(00)80237-3Get rights and contentReferences (0)Cited by (0)View full textCopyright © 2000 Published by Elsevier B.V.